---
title: Ardena vs Siegfried Holding
slug_a: ardena
slug_b: siegfried
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ardena/siegfried
---

# Ardena vs Siegfried Holding

Side-by-side profile data from each company listing on this directory.

## Ardena

- Profile: [/companies/ardena](/companies/ardena)

Ardena — Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.

Services: 13. Modalities: 3. Indications: 0. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- ADC (Antibody-Drug Conjugate) Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Oral Solid Dose (OSD)
- HPAPI
- DEA licensed

## Siegfried Holding

- Profile: [/companies/siegfried](/companies/siegfried)

Siegfried Holding — Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.

Services: 18. Modalities: 2. Indications: 0. Locations: 6. Certifications: 4. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Viral Vector Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Ophthalmic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Oral Solid Dose (OSD)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Hydrogenation
- Cryogenic (−80 °C)
- Flow Chemistry